Valsartan Impurity, Probable Cause of Cancer

Florida Pharacautical Liability Attorney

On July 13, 2018, the United States Food and Drug Administration (FDA) sent out alerts to health care professionals and patients regarding a voluntary recall of medications containing valsartan, after an impurity was found. The impurity is an organic chemical known as nitrosodimethylamine (“NDMA”). NDMA is classified as a probable human carcinogen. According to the … Read More